James Huston BS, PhD

James is a Pioneer in protein and antibody engineering with consistent success in strategic invention and innovation. He is a Research leader with accomplishments in the rapidly evolving and competitive environments faced by biotechnology and multi-national pharmaceutical companies. He has Strong expertise for problem-solving in R&D and strategic innovation, bridging disciplines within biologics research, and identifying important new opportunities. Current IP comprises 42 granted patents and ~60 published papers in multiple disciplines and diseases; over 130 US/ international presentations. In the 12 April 2013 global survey by Terrrapinn, ranked # 5 among the Top 50 most influential people in the Antibody Industry.